Form 4: REGENXBIO Officer's Tax-Related Stock Sale

REGENXBIO's Chief Strategy & Legal Officer, Patrick J. Christmas, reported a disposition of 4,699 shares of common stock to cover tax obligations related to RSU vesting.

Summary

• Patrick J. Christmas, Chief Strategy & Legal Officer of REGENXBIO Inc., reported a transaction involving the company's common stock.
• 4,699 shares of REGENXBIO Inc. common stock were disposed of.
• The disposition was made to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs).
• The shares were withheld at a price of $8.19 per share.
• Following this transaction, Patrick J. Christmas beneficially owns 151,411 shares of common stock.
• The restricted stock units were originally granted on August 1, 2024, and vested on August 1, 2025.

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares for tax withholding upon RSU vesting, which is a common and expected event for executive compensation. It does not indicate a change in company fundamentals or outlook.

Positives

• Vesting of restricted stock units indicates earned compensation for the officer.

Negatives

• Disposition of shares, though for tax purposes, reduces the officer's direct holdings.

Related Party Transactions

• Disposition of shares to the issuer (REGENXBIO Inc.) to satisfy tax obligations related to restricted stock unit vesting.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine administrative transaction for executive compensation.
• Employees: Reflects standard executive compensation practices, indicating the vesting of previously granted equity awards.

Key Dates

Recommendation

This Form 4 reports a routine disposition of shares by an officer to cover tax obligations upon the vesting of restricted stock units. Such transactions are administrative in nature and do not typically reflect a change in the company's fundamental performance, strategic direction, or the officer's confidence in the company. Therefore, it provides no new information to warrant a change in investment recommendation.

Keywords

REGENXBIO, RGNX, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, RSU, Tax Withholding, Patrick J. Christmas